Radiopharm Theranostics revenue was $1.06M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, RADX annual revenue was $199.5k, with -1.1% growth year-over-year.
RADX past revenue growth
How has RADX's revenue growth performed historically?
Radiopharm Theranostics (NASDAQ: RADX) reported Q4 2024 revenue of N/A up N/A year over year. In the same quarter last year, Radiopharm Theranostics's revenue was N/A.
What was Radiopharm Theranostics's revenue in 2024?
Radiopharm Theranostics's annual revenue for the twelve months ending Jun 30, 2024 was $199.49 thousand, a 1.06% decrease year over year.
How much does Radiopharm Theranostics make in a day?
Based on Radiopharm Theranostics annual revenue for the past two years, RADX makes an average of $549.47 per day.
What was Radiopharm Theranostics's annual revenue growth in the past year?
As of Q2 2025, Radiopharm Theranostics's revenue has grown null year over year. Radiopharm Theranostics's revenue in the past year totaled $1.06 million.
How much does Radiopharm Theranostics make in a year?
Radiopharm Theranostics's revenue by year for the past two years is:
Radiopharm Theranostics's revenue for the twelve months ending Jun 30, 2024 was $199.49 thousand, a 1.06% decrease year over year.
Radiopharm Theranostics's annual revenue for Jun 30, 2023 was $201.63 thousand, a Infinity% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.